Advisornet Financial’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.5K Hold
55
– – ﹤0.01% 1522
2026
Q1
$9.49K Sell
55
-4
-7% -$742 ﹤0.01% 1554
2025
Q4
$11.8K Buy
59
+4
+7% +$726 ﹤0.01% 1491
2025
Q3
$8.61K Buy
55
+1
+2% +$159 ﹤0.01% 1566
2025
Q2
$8.19K Sell
54
-16
-23% -$2.13K ﹤0.01% 1536
2025
Q1
$10.5K Sell
70
-13
-16% -$2.18K ﹤0.01% 1393
2024
Q4
$15.3K Sell
83
-7
-8% -$1.35K ﹤0.01% 1210
2024
Q3
$17.7K Sell
90
-15
-14% -$3.12K ﹤0.01% 1245
2024
Q2
$21.7K Sell
105
-14
-12% -$3.17K ﹤0.01% 1073
2024
Q1
$32.2K Buy
119
+71
+148% +$17K ﹤0.01% 942
2023
Q4
$11.3K Buy
48
+3
+7% +$590 ﹤0.01% 1274
2023
Q3
$8.82K Sell
45
-8
-15% -$1.64K ﹤0.01% 1270
2023
Q2
$11.1K Buy
53
+5
+10% +$995 ﹤0.01% 1295
2023
Q1
$9.69K Hold
48
– – ﹤0.01% 1310
2022
Q4
$10.5K Sell
48
-18
-27% -$3.93K ﹤0.01% 1281
2022
Q3
$13K Buy
66
+3
+5% +$648 ﹤0.01% 1251
2022
Q2
$13K Sell
63
-10
-14% -$2.44K ﹤0.01% 1271
2022
Q1
$21K Buy
73
+10
+16% +$3.08K ﹤0.01% 1225
2021
Q4
$24K Hold
63
– – ﹤0.01% 1243
2021
Q3
$26K Buy
+63
New +$26.2K ﹤0.01% 1181
2018
Q3
– Sell
-13
Closed -$1K – 1488
2018
Q2
$1K Buy
+13
New +$1.41K ﹤0.01% 1442

Other funds holding CRL

Advisornet Financial's CRL Position: Q2 2026 in Review

Advisornet Financial held its Charles River Laboratories (CRL) position steady in Q2 2026 at 55 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

Advisornet Financial first reported a position in CRL in Q2 2018 and has held it in 21 quarters since. The position peaked at $32.2K in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Advisornet Financial held 55 shares of Charles River Laboratories worth $12.5K as of Q2 2026.
  • Advisornet Financial left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1522 holding.
  • Advisornet Financial first reported a position in Charles River Laboratories in Q2 2018 and has held it in 21 quarters since.
  • Advisornet Financial's Charles River Laboratories position peaked at $32.2K in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.